ClinicalTrials.gov
public full text
Public Domain
Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome
The purpose of this study is to assess the efficacy and safety of intravitreal injection of aflibercept for the treatment of Choroidal Neovascularization (CNV) secondary to presumed ocular histoplasmosis syndrome (POHS).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization#854466
- Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients#967634
- Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery#909143
- Use of Eylea for the Treatment of an Optic Nerve Hemangioma#982539
- iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications#840006
Record · ID 886186
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive